The frequencies of cases showing high expression, which was defined as positive expression in>75% of tumor cells, were 55.2% (91/167) for EZH2, 32.3% (54/167) for SUZ12, 37.1% (62/167) for H3K27me3, and 31.1% (52/167) for BMI1. This evidence concerns the gene SUZ12 and neoplasm.